Just two days of oatmeal cut bad cholesterol by 10%

Source: Hacker News

Background

A clinical trial conducted by the University of Bonn examined whether eating almost exclusively oatmeal for just two days could improve cholesterol levels in people with metabolic syndrome (a cluster of excess body weight, high blood pressure, elevated blood sugar, and abnormal lipid levels).

• Intervention: 48 h calorie‑restricted diet composed almost entirely of oatmeal.
• Control: Calorie‑restricted diet without oats.

The oat‑based group showed a markedly greater improvement in cholesterol, and the reduction persisted for at least six weeks. Gut‑microbiome analyses suggested that microbial metabolites may mediate these benefits.

A Historic Diabetes Therapy Revisited

Oats have long been linked to metabolic health. In the early 20th century, German physician Carl von Noorden used oats to treat diabetic patients with striking results.

“Today, effective medications are available to treat patients with diabetes,” explains Marie‑Christine Simon, junior professor at the Institute of Nutritional and Food Science, University of Bonn. “As a result, this method has been almost completely overlooked in recent decades.”

The new study focused on participants without diabetes but with metabolic syndrome, a condition that raises the risk of developing diabetes.

300 g of Oatmeal per Day

During the intensive phase:

• Participants ate boiled oatmeal three times daily, with only small amounts of fruit or vegetables allowed.
• Total intake: 300 g of oatmeal per person per day (≈ ½ of their usual caloric intake).
• Sample size: 32 volunteers (both men and women) completed the two‑day oat intervention.

Both the oat and control groups lost weight and experienced some benefits from calorie restriction, but the oat group showed stronger improvements:

• LDL‑cholesterol: ↓ 10 % (a substantial reduction, though not as large as modern lipid‑lowering drugs).
• Weight loss: ≈ 2 kg on average.
• Blood pressure: modest decline.

Lowering LDL is crucial because high LDL can lead to plaque formation, vessel narrowing, and potentially fatal heart attacks or strokes.

Gut Microbiome Changes May Explain the Effect

Lead author Linda Klümpen reported that oatmeal consumption increased the abundance of specific gut bacteria. These microbes produce metabolic by‑products that:

1. Nourish intestinal cells and support gut barrier function.
2. Enter the bloodstream and influence distant organs.

Key findings:

• Phenolic compounds (e.g., ferulic acid) generated from oat breakdown have been shown in animal studies to favorably affect cholesterol metabolism.
• Certain microbes help eliminate the amino acid histidine; without this elimination, histidine can be converted into a compound that promotes insulin resistance, a hallmark of diabetes.

Short Intensive Plan Outperformed Longer Moderate Intake

• Two‑day intensive oat diet: LDL‑lowering effects remained detectable six weeks later.
• Six‑week moderate intake: Participants ate 80 g of oatmeal per day without additional calorie restriction; only modest changes were observed.

“A short‑term oat‑based diet at regular intervals could be a well‑tolerated way to keep cholesterol within the normal range and prevent diabetes,” says Junior Professor Simon.

Future work will test whether repeating the intensive oat protocol every six weeks yields a permanent preventive effect.

How the Randomized Controlled Trials Were Conducted

*Two control participants withdrew for personal reasons.

• Design: Both phases were randomized controlled trials (RCTs). Participants were randomly assigned to the oat or control arm.
• Blinding: Full blinding is difficult in nutrition studies because participants know what they eat; this trial was therefore open‑label.

Take‑away Messages

1. Brief, high‑dose oatmeal consumption (300 g/day for two days) combined with calorie restriction can sharply lower LDL cholesterol in people with metabolic syndrome.
2. Gut‑microbiome modulation appears to be a key mechanism, with bacterial metabolites (e.g., ferulic acid) influencing lipid metabolism and insulin sensitivity.
3. Longer, low‑dose oatmeal intake without calorie restriction yields only modest benefits.
4. Future research should explore periodic intensive oat interventions as a sustainable, low‑cost strategy for cardiovascular and metabolic disease prevention.

Study Design and Blinding

Laboratory teams analyzing blood and stool samples were unaware of which group the samples came from. The same blinding applied to blood‑pressure and weight measurements, reducing the chance that expectations could influence the results.

Baseline and Follow‑Up Assessments

• Baseline (pre‑intervention):

  • Blood and stool sample collection
  • Measurements: blood pressure, weight, height, waist circumference, body fat

• Follow‑up time points:

  • Immediately after the two‑day oat phase
  • At 2 weeks, 4 weeks, and 6 weeks post‑intervention

At each follow‑up, the same set of measurements and sample collections were repeated. The six‑week oatmeal group underwent identical testing procedures.

Sample Analyses

• Blood samples:

  • LDL cholesterol levels
  • Dihydroferulic acid (a phenolic compound thought to be produced by beneficial gut bacteria)

• Stool samples:

  • Identification of bacterial species by isolating 16S rRNA, a bacterial “fingerprint” that varies slightly between species
  • Examination of metabolic by‑products present in the gut

Funding

The study received financial support from:

• German Federal Ministry of Education and Research (BMBF)
• German Diabetes Association (DDG)
• German Research Foundation (DFG)
• German Cereal Processing, Milling and Starch Industries’ Association (VGMS)
• RASO Naturprodukte